Correlation Between Eliem Therapeutics and Metacrine

Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Metacrine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Metacrine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eliem Therapeutics and Metacrine, you can compare the effects of market volatilities on Eliem Therapeutics and Metacrine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Metacrine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Metacrine.

Diversification Opportunities for Eliem Therapeutics and Metacrine

0.08

Correlation Coefficient

Eliem Therapeutics  Metacrine

Significant diversification

The 3 months correlation between Eliem and Metacrine is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Metacrine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Metacrine and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Metacrine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Metacrine has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Metacrine go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Metacrine

If you would invest  49.00  in Metacrine on September 24, 2024 and sell it today you would earn a total of  0.00  from holding Metacrine or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	0.88%
Values	Daily Returns

Eliem Therapeutics  vs.  Metacrine

Eliem Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Metacrine

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Metacrine has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Metacrine is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Eliem Therapeutics and Metacrine

The main advantage of trading using opposite Eliem Therapeutics and Metacrine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Metacrine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Metacrine will offset losses from the drop in Metacrine's long position.

The idea behind Eliem Therapeutics and Metacrine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.